Citadel Advisors’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.71M Buy
174,700
+67,600
+63% +$1.35M ﹤0.01% 4854
2025
Q4
$1.75M Buy
107,100
+41,300
+63% +$624K ﹤0.01% 6198
2025
Q3
$769K Sell
65,800
-81,200
-55% -$1.06M ﹤0.01% 8119
2025
Q2
$1.7M Buy
147,000
+3,800
+3% +$34.6K ﹤0.01% 6025
2025
Q1
$1.25M Buy
143,200
+102,300
+250% +$1.29M ﹤0.01% 6465
2024
Q4
$587K Sell
40,900
-24,600
-38% -$388K ﹤0.01% 8200
2024
Q3
$1.48M Buy
65,500
+39,300
+150% +$812K ﹤0.01% 6084
2024
Q2
$510K Sell
26,200
-82,100
-76% -$2.15M ﹤0.01% 8000
2024
Q1
$4.06M Buy
108,300
+5,200
+5% +$228K ﹤0.01% 4270
2023
Q4
$5.77M Sell
103,100
-39,300
-28% -$1.71M ﹤0.01% 3584
2023
Q3
$5.87M Buy
142,400
+40,200
+39% +$2.09M ﹤0.01% 3399
2023
Q2
$5.71M Buy
102,200
+31,500
+45% +$1.7M ﹤0.01% 3443
2023
Q1
$3.94M Buy
70,700
+51,100
+261% +$2.39M ﹤0.01% 4188
2022
Q4
$714K Sell
19,600
-49,200
-72% -$1.61M ﹤0.01% 7498
2022
Q3
$1.96M Buy
68,800
+37,500
+120% +$1.43M ﹤0.01% 5629
2022
Q2
$1.42M Sell
31,300
-35,300
-53% -$1.83M ﹤0.01% 6245
2022
Q1
$5.07M Sell
66,600
-4,000
-6% -$350K ﹤0.01% 4146
2021
Q4
$10.5M Buy
70,600
+30,900
+78% +$4.73M ﹤0.01% 2998
2021
Q3
$5.78M Buy
39,700
+7,800
+24% +$1.34M ﹤0.01% 4033
2021
Q2
$6.25M Buy
31,900
+4,700
+17% +$851K ﹤0.01% 3970
2021
Q1
$4.92M Sell
27,200
-5,100
-16% -$881K ﹤0.01% 4292
2020
Q4
$4.57M Sell
32,300
-400
-1% -$58K ﹤0.01% 3844
2020
Q3
$4.08M Buy
32,700
+8,500
+35% +$892K ﹤0.01% 3460
2020
Q2
$2.16M Sell
24,200
-6,300
-21% -$491K ﹤0.01% 4430
2020
Q1
$1.9M Buy
30,500
+15,600
+105% +$1.22M ﹤0.01% 4219
2019
Q4
$1.14M Buy
+14,900
New +$896K ﹤0.01% 5362

Other funds holding TXG